The collateral was the building. The loan was really on the practice.

The subject was an owner-occupied medical office building being financed under the SBA programs, with a physician group using the building for its own practice. The sponsor's case rested on the real estate: a conservative loan-to-value against an appraised building, and a practice that comfortably occupied it.

The SBA programs finance owner-occupied real estate, with the 504 structure for the building and the 7(a) structure available for practice-related needs. But while the real estate is the collateral, the loan is repaid from the occupying practice's cash flow — and the SBA's process looks at the global picture: the practice's ability to service the debt, not the building alone. The question the file turned on was not the value of the building but the durability of the practice's cash flow: whether a sound practice today would generate the income to service the loan through the reimbursement, payor, and physician realities that drive a medical practice's economics.

The intuitive way to underwrite a loan secured by real estate is the real estate: take a conservative loan-to-value against an appraised building, confirm the practice occupies it, and read the risk off the collateral. On that logic the deal looked safe — a conservative loan, an appraised building, a practice in place. The collateral did the persuading.

It was also treating the building as the source of repayment, when the loan is repaid by the practice's cash flow, and a medical practice's cash flow is exposed to forces a real-estate appraisal does not capture.

An owner-occupied medical practice loan is a healthcare-practice credit secured by real estate, not a passive real-estate loan — the building is the collateral but the practice's cash flow is the repayment, and that cash flow is exposed to reimbursement, payor mix, physician concentration, and occupancy cost in ways a real-estate-only analysis does not see. A real-estate appraisal answers what the building is worth; it does not answer whether the practice can pay, and several forces specific to a medical practice determine that. Reimbursement is the first: a practice's revenue depends on what payors pay for its services, and physician reimbursement has been under sustained pressure, with the rates for many services declining in real terms over time, so a practice's revenue per service is not a fixed quantity. Payor mix is the second: the share of revenue from Medicare, Medicaid, and commercial payors — each of which pays differently for the same service, and some of which pay well below others — shapes how much the practice actually collects, and a shift in mix moves the cash flow. Physician concentration is the third: a practice's income often depends on a small number of physicians, so the departure, retirement, or reduced productivity of a key physician is a direct threat to the cash flow that repays the loan. And occupancy cost is the fourth: the building's debt service is a fixed cost the practice must carry as a share of its revenue, so a practice that takes on more building than its cash flow comfortably supports is exposed if revenue softens. None of these is visible in the building's value — they are visible only in the practice's global cash flow and its sensitivity to the forces that drive it. A loan underwritten on the collateral alone, without the practice credit and its reimbursement and payor exposure, misjudges the thing that actually repays it.

The inflection is that the building's value was real and was not the repayment — the loan was a practice credit secured by real estate, and the bankable question was the durability of the practice's cash flow, not the value of the building. Re-analyzed on the practice's global cash flow — its revenue and its sensitivity to reimbursement and payor mix, its dependence on key physicians, and the building's occupancy cost as a share of revenue — the deal's risk came into focus where it actually lives: in the practice's ability to service the debt through the realities of a medical practice's economics, not in the appraised value of the building. The loan was sized to the practice credit and its exposures, with the real estate as the collateral behind it rather than the basis of the underwriting. The bankable analysis was the practice's cash flow and its reimbursement, payor, and physician sensitivities, not the building's value alone. The relevant analysis was whether the practice could pay, not what the building was worth.

The practice's global cash flow. Repayment was analyzed on the occupying practice's global cash flow — its revenue and its capacity to service the debt — rather than the building's value, because the practice, not the real estate, repays the loan.

Reimbursement sensitivity. The practice's exposure to reimbursement was examined, because a practice's revenue per service depends on what payors pay and physician reimbursement has been under sustained real-terms pressure, so the revenue line is not a fixed quantity.

Payor mix. The practice's payor mix — the share of revenue from Medicare, Medicaid, and commercial payors, each of which pays differently — was analyzed, because the mix shapes what the practice actually collects and a shift in it moves the cash flow.

Physician concentration. The practice's dependence on a small number of physicians was examined as a key-person risk, because the departure, retirement, or reduced productivity of a key physician is a direct threat to the cash flow that repays the loan.

Occupancy cost as a share of revenue. The building's debt service was weighed as a fixed cost against the practice's revenue, surfacing whether the practice had taken on more building than its cash flow comfortably supports.

Loan sized to the practice credit. The loan was sized to the practice's global cash flow and its exposures, with the real estate as the collateral behind it, so the SBA underwriting reflected the credit that actually repays the loan rather than the value of the building alone.

The credit file replaced a collateral-only view with an analysis of the practice's global cash flow and explained why a loan secured by real estate is repaid by the practice. The analysis examined the practice's reimbursement and payor-mix exposure, its dependence on key physicians, and the building's occupancy cost as a share of revenue, and sized the loan to the practice credit with the real estate as the collateral behind it. The SBA and the lender underwrote the loan to the global cash flow, and the appraiser's value established the collateral. The feasibility analysis answered the program's expectation by evaluating whether the practice could pay, which is where owner-occupied medical credits are most often misjudged.

The SBA financing closed sized to the practice's global cash flow and its reimbursement, payor, and physician exposures, with the real estate as the collateral behind it — not to the appraised value of the building alone. The inflection was not that the building was weak; it was sound collateral. It was that the loan is repaid by the practice's cash flow rather than the building, and the bankable deal was the one underwritten to the durability of that cash flow rather than to the value of the real estate.

• 01An owner-occupied medical loan is a practice credit secured by real estate. The building is the collateral, but the practice's cash flow is the repayment, and the two are different questions.
• 02Reimbursement and payor mix drive the revenue. A practice's revenue per service depends on what payors pay — under sustained real-terms pressure — and on its mix of Medicare, Medicaid, and commercial payors, none of which a real-estate appraisal captures.
• 03Physician concentration is a key-person risk. A practice's income often depends on a few physicians, so a key departure, retirement, or productivity decline is a direct threat to the cash flow that repays the loan.
• 04Underwrite the practice, with the building behind it. The bankable analysis sizes the loan to the practice's global cash flow and its exposures, with the real estate as the collateral — not to the appraised value alone.